The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: Press brief on the Danish model for cancer
Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark talks about cancer in Denmark and the role of ESMO in this press briefing. Dr Lassen gives an overview of the Danish model of cancer and the partners involved. He highlights the establishment of cancer pathways and the idea of looking at cancer as an acute disease, which involves being referred immediately without delay after a cancer diagnosis. Further, he talks about the unique identification number of each citizen in Denmark and its role in quality control of the care. Finally, he addresses the cancer statistics in Denmark and how they are not the best when compared to neighboring countries. The National Cancer Plans have improved outcome as he explains and he also talks about changes to the legislation in terms of smoking in public places and future plans.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
